USDA eases rules for faster crop innovation
The USDA's Animal and Plant Health Inspection Service (APHIS) has revised its biotechnology regulations, expanding the exemptions for modified plants, as announced in a recent update under 7 CFR part 340.
This regulatory enhancement is endorsed by the Biotechnology Innovation Organization (BIO), which views it as a crucial step towards modernizing biotech advancements in agriculture.
By broadening the scope of these exemptions, the USDA APHIS aims to foster a more innovative and responsive agricultural biotech industry.
This change is expected to streamline the process by which new agricultural products are brought to market, thereby ensuring they are safe and effective more rapidly than before.
BIO has actively supported the revision of these regulations, emphasizing the positive impact on not only the industry giants but also smaller firms and academic institutions involved in agricultural biotech.
The organization highlights the inclusion of extensive public and stakeholder feedback, with nearly 6,500 comments considered, underscoring the USDA's commitment to collaborative regulatory development.
With these updates, BIO looks forward to continued collaboration with the USDA to further minimize obstacles for biotech innovators.
This regulatory change is poised to enhance the diversity of biotechnologically developed crops and support sustainable farming practices, which are vital for future food security and economic stability in the U.S. and globally.